{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:31:17Z","timestamp":1733877077786,"version":"3.30.1"},"reference-count":9,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Basic Clin Pharma"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0976-0105.195126","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T07:09:36Z","timestamp":1480662576000},"page":"38","source":"Crossref","is-referenced-by-count":3,"title":["Unusual Case of an Alcoholic with Liver Injury from Sulfasalazine Use"],"prefix":"10.4103","volume":"8","author":[{"given":"Umair","family":"Masood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonny","family":"Nijjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Krenzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0976-0105.195126-1","first-page":"950","volume-title":"ACG clinical guideline: The diagnosis and management of idiosyncratic drug-induced liver injury","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0976-0105.195126-2","first-page":"1058","volume-title":"N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse events","author":"Tanigawara","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"key-10.4103\/0976-0105.195126-3","first-page":"220","volume-title":"Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis","author":"Kitas","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"key-10.4103\/0976-0105.195126-4","first-page":"731","volume-title":"Drug-related hepatotoxicity","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0976-0105.195126-5","first-page":"272","volume-title":"Criteria of drug-induced liver disorders.Report of an international consensus meeting","author":"B\u00e9nichou","year":"1990","journal-title":"J Hepatol"},{"key":"key-10.4103\/0976-0105.195126-6","first-page":"353","volume-title":"Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): An update","author":"Tas","year":"2003","journal-title":"Dermatology"},{"key":"key-10.4103\/0976-0105.195126-7","first-page":"427","volume-title":"Hypersensitivity reaction to sulfasalazine: Skin rash, fever, hepatitis and activated lymphocytes","author":"Leroux","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.4103\/0976-0105.195126-8","first-page":"1409","volume-title":"Chronic hepatitis.An update on terminology and reporting","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0976-0105.195126-9","first-page":"48","volume-title":"Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events","author":"Jobanputra","year":"2008","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Journal of Basic and Clinical Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T07:11:33Z","timestamp":1480662693000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbclinpharm.org\/text.asp?2017\/8\/1\/38\/195126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["195126"],"URL":"https:\/\/doi.org\/10.4103\/0976-0105.195126","relation":{},"ISSN":["0976-0105"],"issn-type":[{"type":"print","value":"0976-0105"}],"subject":[],"published":{"date-parts":[[2017]]}}}